During the past decade, Hopital Civil Marie Curie conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 4 clinical trials were completed, i.e. on average, 21.1% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 4 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hopital Civil Marie Curie" #1 sponsor was "Université Libre de Bruxelles" with 3 trials, followed by "Abbott Medical Devices" with 2 trials sponsored, "Bayer" with 2 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital Civil Marie Curie" #1 collaborator was "CHU de Charleroi" with 4 trials as a collaborator, "Australian and New Zealand Intensive Care Society Clinical Trials Group" with 1 trials as a collaborator, "Hamilton Health Sciences Corporation" with 1 trials as a collaborator, "KCE Belgian Healthcare Knowledge Centre" with 1 trials as a collaborator and "NSABP Foundation Inc" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Hopital Civil Marie Curie" are "Atrial Fibrillation" (2 trials), "Delirium" (2 trials), "Atrial Flutter" (1 trials), "Breast Cancer" (1 trials) and "Candidemia" (1 trials). Many other conditions were trialed in "Hopital Civil Marie Curie" in a lesser frequency.

Most popular intervention types in "Hopital Civil Marie Curie" are "Drug" (10 trials), "Other" (5 trials), "Device" (3 trials), "Procedure" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Empagliflozin" (2 trials), "0.9% sodium chloride solution" (1 trials), "AMPLATZER™ LAA Occluder" (1 trials) and "APX001" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Civil Marie Curie" are 23 trials for "All" genders.

Currently, there are NaN active trials in "Hopital Civil Marie Curie". 1 are not yet recruiting, 3 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Hopital Civil Marie Curie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Civil Marie Curie, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".